Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Sirona Biochem Corp V.SBM

Alternate Symbol(s):  SRBCF

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.


TSXV:SBM - Post by User

Bullboard Posts
Post by Haidukon Jul 05, 2016 6:37am
301 Views
Post# 25022129

“Business Development Presentation”

“Business Development Presentation”
The presentation made at the occasion of the “Innocos World Beauty Innovation Summit” (in the early days of June) – to a professional audience – is now online on SBM website (and should be read in parallel with the narrative “Imcas Abstract Presentation”).
 
For those interested with the list of potential partners (as compared to the January presentation): Pierre Fabre is Out, LG Life Sciences is In.
 
PS: Laneige is a South Korean cosmetics brand owned by Amore Pacific.
 
I remain confident that multiple deals will be concluded before year-end.

Meanwhile, I do not ignore that the short term evolution of the stock price (during the summer months) will be dictated by the timing of any announcement (or by the lack of it)...
 
GLTA
 
Haiduk

Bullboard Posts